Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study on the Immune Response Characteristics of Novel Coronavirus and Influenza Virus Infection

NCT06667063 is registered in ClinicalTrials.gov with Zhongnan Hospital as lead sponsor.

NCT NCT06667063
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06667063 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study on the Immune Response Characteristics of Novel Coronavirus and Influenza Virus Infection
Lead sponsor
Zhongnan Hospital
Phase
Observational
Overall status
Recruiting
Start date
September 19, 2024
Completion date
June 30, 2025
Enrollment
130 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, influenza